Wenqiang Wei

Wenqiang Wei


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2025 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
XWXiong Wang
Xiong Wang
QGQing Gu
Qing Gu
SZShuming Zi
Shuming Zi
WWWenqiang Wei
Wenqiang Wei
BCBiao Cheng
Biao Cheng
LCLiehu Cao
Liehu Cao
Background: Posterior cruciate ligament (PCL) tibial avulsion fractures are relatively rare injuries that often result in chronic pain, limited range of motion, knee instability, and osteoarthritis. Most cases require surgical intervention to restore the fragment’s normal anatomy, the ligament’s tension, and the knee joint’s stability. In this study, we propose a novel approach utilizing a modified suture bridge fixation technique to treat PCL tibial avulsion fractures and explore the clinical outcome and applicability.Methods: We retrospectively reviewed and collected the clinical data from March 2020 to April 2023. Of the 24 patients (14 males and 10 females) with PCL tibial avulsion fractures who underwent modified suture bridge fixation technique were enrolled in the study. The surgical data of the surgery time and intraoperative blood loss were analyzed. The knee range of motion (ROM), the Lysholm knee scoring scale, and the International Knee Documentation Committee (IKDC) were used to evaluate the recovery of knee joint function.Results: All 24 patients were followed up for a duration ranging from 11 to 16 months, with an average of 13.00 ± 1.32 months. The surgery time was 40∼60 min, with a mean of 50.88 ± 4.85 min. The intraoperative blood loss was approximately 25∼45 mL, averaging 36.75 ± 4.89 mL. No instances of wound infection, neurovascular injuries, fracture nonunion, fixation failure, deep vein thrombosis, or secondary operation were reported during follow-up. The knee joint range of motion (ROM) was 118°∼134°, with an average of 127.46° ± 4.16° at the final follow-up. The Lysholm score was 41.17 ± 3.48 at the preoperative stage and improved to 90.25 ± 2.59 at the final follow-up. The IKDC score was 40.38 ± 2.16 at the preoperative stage, and 88.54 ± 1.77 at the final follow-up.Conclusion: The results indicate that the novel approach utilizing a modified suture bridge fixation technique can provide effective stabilization and favorable clinical outcomes. The suture bridge structure can be applied to displaced posterior cruciate ligament (PCL) tibial avulsion fractures through its compression capabilities, especially in comminuted fractures. This procedure is straightforward, minimizing the risk of injury to peripheral neurovascular structures and eliminating the need for a second operation. Consequently, this technique represents a viable alternative treatment option for primary care facilities or hospitals that lack arthroscopic equipment.

8 April 2025 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
ZZZhi Zhang
Zhi Zhang
XWXiong Wang
Xiong Wang
QZQirong Zhou
Qirong Zhou
XXXingwen Xu
Xingwen Xu
JCJin Cui
Jin Cui
LCLiehu Cao
Liehu Cao
Although intramedullary nailing has been established as the gold standard for treating femoral shaft fractures, nonunion following intramedullary nailing remains a major concern for clinicians, severely affecting patients’ walking ability and quality of life. Presently, there are certain controversies and deficiencies in nonunion classification and treatment. Herein, we propose a novel classification system for aseptic femoral shaft nonunion after intramedullary nailing based on X-ray-assessed nailing morphology and stability. Furthermore, we sought to explore the new classification’s clinical significance and management implications. This retrospective study involved the analysis of clinical data collected from 82 patients with aseptic bone nonunion after intramedullary nailing of femoral shaft fractures between 2010 and 2022. The patients were classified into four groups based on intramedullary nailing stability and bone defect existence, as revealed in X-ray images. The four classifications were as follows: Type I (intramedullary nailing is stable without bone defect), Type II (intramedullary nailing is stable with bone defect), Type III (intramedullary nailing is not stable without bone defect), and Type IV (intramedullary nailing is not stable with bone defect). Based on the novel classifications, we introduced individualized treatment methods. Type I patients underwent dynamization, and Type II patients received bone grafting and plate fixation. Type III patients underwent larger intramedullary nail exchange or plate fixation, and Type IV patients received larger intramedullary nail exchange and plate fixation with bone graft or double plate fixation with bone graft. Data on relevant indicators were collected. All patients recovered well with no complications. The average surgery times for Types I-IV were 0.4 ± 0.1, 0.8 ± 0.2, 1.1 ± 0.4, and 1.6 ± 0.4 h, respectively. Furthermore, the mean blood loss volumes for Types I-IV were 23.4 ± 4.8, 53.3 ± 8.4, 56.3 ± 7.9, and 125.2 ± 10.8 ml, respectively. The average bone healing time of all 82 patients was 5.1 ± 1.5 months. On the other hand, the mean bone healing times for Types I-IV were 4.6 ± 1.1, 4.7 ± 1.1, 5.1 ± 1.5, and 5.7 ± 1.8 months, respectively. Furthermore, the LEFS scores for Types I-IV were 68.7 ± 3.5, 69.8 ± 3.1, 66.8 ± 3.8, and 68.6 ± 2.9 points, respectively. The mean surgery time and bleeding volume increased gradually from Types I to IV (p < 0.05) but with no significant difference between Types II and III. Moreover, there were no statistical differences in fracture healing times, LEFS scores, age, and nonunion durations across the four classifications. The proposed novel classification system could achieve accurate diagnosis and guidance for clinical management of aseptic femoral shaft nonunion after intramedullary nailing. The corresponding individualized treatment approaches could improve prognostic outcomes and healing rates and alleviate postoperative complications. Not applicable.

13 July 2026 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
XWXiong Wang
Xiong Wang
QGQing Gu
Qing Gu
FZFeifei Zhang
Feifei Zhang
LLLu Li
Lu Li
JZJinqiang Zhang
Jinqiang Zhang
SCSong Chen
Song Chen
Rotator cuff injury (RCI) represents a leading cause of shoulder pain and functional impairment, imposing a considerable burden on patients’ quality of life and healthcare systems worldwide. The subacromial bursa (SAB), a critical anatomical structure located between the acromion and rotator cuff tendons, has traditionally been regarded as a primary pathological contributor to pain generation, inflammation, and tendon degeneration. Aberrant inflammatory signaling, fibrotic remodeling, and nociceptive sensitization within the diseased SAB can disrupt the homeostatic tendon microenvironment and impair intrinsic healing capacity, thereby supporting the historical rationale for routine bursectomy during surgical repair. Paradoxically, accumulating evidence challenges this conventional view, suggesting that the SAB also serves as a biologically active, endogenous regenerative reservoir. It contains mesenchymal stem cells (MSCs) with promising proliferative and tenogenic potential, secretes bioactive growth factors, and modulates the local immune microenvironment to promote reparative and anti-inflammatory responses conducive to tendon healing. This dual biological role presents an important clinical dilemma in arthroscopic rotator cuff repair: should surgeons resect pathological bursal tissue to alleviate the inflammatory burden and improve visualization, or selectively preserved to maintain its potential regenerative capacity? In this comprehensive narrative review, we critically synthesize current evidence regarding the pathological and regenerative functions of the SAB in RCI, critically evaluate the ongoing controversy between bursal resection versus preservation, and summarize emerging SAB-targeted therapeutic strategies. Furthermore, we integrate multi-omics insights into bursa biology aimed at moderating the local microenvironment. Finally, we highlight current translational challenges and future directions to inform biologically guided and evidence-based management of the SAB for rotator cuff repair.